{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:29:25Z","timestamp":1790861365567,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.suc.2021.09.005","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T22:37:50Z","timestamp":1637188670000},"page":"117-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Management of Decompensated Cirrhosis and Associated Syndromes"],"prefix":"10.1016","volume":"102","author":[{"given":"Shaun","family":"Chandna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Rodr\u00edguez","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Gallegos-Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.suc.2021.09.005_bib1","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.14309\/ajg.0000000000000422","article-title":"The growing challenge of advanced liver disease due to alcohol use in the United States","volume":"114","author":"Gallegos-Orozco","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14309\/ajg.0000000000000380","article-title":"Alcoholic liver disease epidemiology in the united states: a retrospective analysis of 3\u00a0US databases","volume":"115","author":"Dang","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.suc.2021.09.005_bib3","doi-asserted-by":"crossref","first-page":"k2817","DOI":"10.1136\/bmj.k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.suc.2021.09.005_bib4","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/j.gastro.2017.01.003","article-title":"Changes in the Prevalence of Hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation","volume":"152","author":"Goldberg","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/TP.0000000000002471","article-title":"Temporal trends associated with the rise in alcoholic liver disease-related liver transplantation in the United States","volume":"103","author":"Cholankeril","year":"2019","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.suc.2021.09.005_bib6","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1399-6576.2011.02480.x","article-title":"The impact of pre-admission morbidity level on 3-year mortality after intensive care: a Danish cohort study","volume":"55","author":"Christiansen","year":"2011","journal-title":"Acta Anaesthesiol Scand"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib7","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00134-012-2523-2","article-title":"Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients","volume":"38","author":"O'Brien","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.suc.2021.09.005_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jcrc.2018.03.018","article-title":"Cirrhotic patients admitted to the ICU for medical reasons: Analysis of 5506 patients admitted to 286 ICUs in 8years","volume":"45","author":"Skurzak","year":"2018","journal-title":"J\u00a0Crit Care"},{"issue":"8","key":"10.1016\/j.suc.2021.09.005_bib9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/MEG.0b013e3283544816","article-title":"Improvement in the prognosis of cirrhotic patients admitted to an intensive care unit, a retrospective study","volume":"24","author":"Galbois","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib10","first-page":"154","article-title":"Cirrhotic patients in the ICU: prognostic markers and outcome","volume":"19","author":"Saliba","year":"2013","journal-title":"Curr Opin Crit Care"},{"issue":"3","key":"10.1016\/j.suc.2021.09.005_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00042737-200403000-00014","article-title":"Outcome predictors of cirrhosis patients admitted to the intensive care unit","volume":"16","author":"Arabi","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.suc.2021.09.005_bib12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/ajg.2013.466","article-title":"The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score","volume":"109","author":"Theocharidou","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.suc.2021.09.005_bib13","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.cgh.2014.08.041","article-title":"Increased survival for patients with cirrhosis and organ failure in liver intensive care and validation of the chronic liver failure-sequential organ failure scoring system","volume":"13","author":"McPhail","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib14","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jhep.2017.07.024","article-title":"Declining mortality in critically ill patients with cirrhosis in Australia and New Zealand between 2000 and 2015","volume":"67","author":"Majumdar","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.suc.2021.09.005_bib15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/CCM.0000000000002961","article-title":"Incidence and outcomes for patients with cirrhosis admitted to the United Kingdom critical care units","volume":"46","author":"McPhail","year":"2018","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.suc.2021.09.005_bib16","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"issue":"22","key":"10.1016\/j.suc.2021.09.005_bib17","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-chronic liver failure","volume":"382","author":"Arroyo","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.suc.2021.09.005_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jhep.2018.12.018","article-title":"Prevalence and short-term mortality of acute-on-chronic liver failure: a national cohort study from the USA","volume":"70","author":"Hernaez","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.suc.2021.09.005_bib19","article-title":"Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis","author":"Mezzano","year":"2021","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.suc.2021.09.005_bib20","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1097\/CCM.0000000000004192","article-title":"Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: cardiovascular, endocrine, hematologic, pulmonary, and renal considerations","volume":"48","author":"Nanchal","year":"2020","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0885066614551144","article-title":"Management of complications of end-stage liver disease in the intensive care unit","volume":"31","author":"DellaVolpe","year":"2016","journal-title":"J\u00a0Intensive Care Med"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2013.10.004","article-title":"Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)","volume":"60","author":"Cordoba","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib23","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/hep.21930","article-title":"Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis","volume":"46","author":"Hassanein","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.suc.2021.09.005_bib24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2036.2009.04211.x","article-title":"Review article: the modern management of hepatic encephalopathy","volume":"31","author":"Bajaj","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib26","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/hep.23216","article-title":"Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy","volume":"50","author":"Bajaj","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.suc.2021.09.005_bib27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","article-title":"Management of the critically ill patient with cirrhosis: a multidisciplinary perspective","volume":"64","author":"Nadim","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.suc.2021.09.005_bib28","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jhep.2010.07.045","article-title":"Infection and systemic inflammation, not ammonia, are associated with Grade 3\/4 hepatic encephalopathy, but not mortality in cirrhosis","volume":"54","author":"Shawcross","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib29","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.jhep.2020.07.013","article-title":"Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy","volume":"73","author":"Rose","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.suc.2021.09.005_bib30","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0168-8278(12)60003-8","article-title":"Management of critically-ill cirrhotic patients","volume":"56","author":"Gin\u00e8s","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.suc.2021.09.005_bib31","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/lt.24815","article-title":"Critical care management of the patient with cirrhosis awaiting liver transplant in the intensive care unit","volume":"23","author":"Olson","year":"2017","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib32","first-page":"171","article-title":"Critical care considerations in the management of acute-on-chronic liver failure","volume":"26","author":"MacDonald","year":"2020","journal-title":"Curr Opin Crit Care"},{"issue":"11","key":"10.1016\/j.suc.2021.09.005_bib33","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1001\/jamainternmed.2014.4746","article-title":"Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial","volume":"174","author":"Rahimi","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1016\/j.suc.2021.09.005_bib34","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.suc.2021.09.005_bib35","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/ajg.2013.219","article-title":"A\u00a0randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy","volume":"108","author":"Sharma","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib36","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/hep.26314","article-title":"Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy","volume":"57","author":"Laleman","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/qjmed\/hcp152","article-title":"Current concepts in the assessment and treatment of hepatic encephalopathy","volume":"103","author":"Cash","year":"2010","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.suc.2021.09.005_bib38","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"Ba\u00f1ares","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.suc.2021.09.005_bib39","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2011.12.056","article-title":"Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure","volume":"142","author":"Kribben","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hep.27849","article-title":"Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis","volume":"62","author":"Gustot","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.suc.2021.09.005_bib41","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ijcard.2012.09.089","article-title":"New insights into cirrhotic cardiomyopathy","volume":"167","author":"M\u00f8ller","year":"2013","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.suc.2021.09.005_bib42","first-page":"1181","article-title":"Bacterial translocation and cardiovascular complications of cirrhosis","volume":"57","author":"Thalheimer","year":"2008","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.suc.2021.09.005_bib43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.suc.2021.09.005_bib44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1213\/ANE.0b013e31822401b2","article-title":"Evaluation of a new software version of the FloTrac\/Vigileo (version 3.02) and a comparison with previous data in cirrhotic patients undergoing liver transplant surgery","volume":"113","author":"Biancofiore","year":"2011","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib45","first-page":"143","article-title":"Management of liver failure in general intensive care unit","volume":"39","author":"Paugam-Burtz","year":"2020","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"4 Pt 1","key":"10.1016\/j.suc.2021.09.005_bib46","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.suc.2021.09.005_bib47","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib48","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/cc2945","article-title":"Clinical review: vasopressin and terlipressin in septic shock patients","volume":"9","author":"Delmas","year":"2005","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2125.1998.00833.x","article-title":"Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve","volume":"46","author":"Annane","year":"1998","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.suc.2021.09.005_bib50","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/beem.2001.0167","article-title":"Relative adrenal failure in intensive care: an identifiable problem requiring treatment?","volume":"15","author":"Beishuizen","year":"2001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.suc.2021.09.005_bib51","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/hep.21101","article-title":"Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock","volume":"43","author":"Tsai","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.suc.2021.09.005_bib52","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/hep.21352","article-title":"Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival","volume":"44","author":"Fern\u00e1ndez","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib53","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0168-8278(05)80070-4","article-title":"Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study","volume":"20","author":"Sol\u00e0","year":"1994","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.suc.2021.09.005_bib54","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib55","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gin\u00e8s","year":"1988","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib56","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.suc.2021.09.005_bib57","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/jhep.2003.50133","article-title":"Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis","volume":"37","author":"Abraldes","year":"2003","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.suc.2021.09.005_bib58","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2014.03.005","article-title":"Nonselective \u03b2 blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"146","author":"Mandorfer","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.suc.2021.09.005_bib59","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serst\u00e9","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib60","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.suc.2021.09.005_bib61","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1055\/s-0038-1672200","article-title":"Critical care management of gastrointestinal bleeding and ascites in liver failure","volume":"39","author":"Rajwani","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"issue":"14","key":"10.1016\/j.suc.2021.09.005_bib62","first-page":"1362","article-title":"Transfusion for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.suc.2021.09.005_bib63","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-2036.2012.05088.x","article-title":"Meta-analysis: vasoactive medications for the management of acute variceal bleeds","volume":"35","author":"Wells","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.suc.2021.09.005_bib64","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/hep.27006","article-title":"Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage","volume":"60","author":"Seo","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.suc.2021.09.005_bib65","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.mayocp.2018.12.020","article-title":"Portal hypertension and related complications: diagnosis and management","volume":"94","author":"Simonetto","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.suc.2021.09.005_bib66","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2036.2011.04746.x","article-title":"Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review","volume":"34","author":"Chavez-Tapia","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib67","doi-asserted-by":"crossref","first-page":"797","DOI":"10.14309\/ajg.0000000000000611","article-title":"Practical tips on TIPS: when and when not to request it","volume":"115","author":"Saab","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib68","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/hep.20559","article-title":"The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension","volume":"41","author":"Boyer","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib69","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0039-1678726","article-title":"Balloon tamponade and esophageal stenting for esophageal variceal bleeding in cirrhosis: a systematic review and meta-analysis","volume":"39","author":"Rodrigues","year":"2019","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib70","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/hep.28360","article-title":"Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: a multicenter randomized, controlled trial","volume":"63","author":"Escorsell","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib71","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cgh.2017.04.042","article-title":"Multicenter external validation of risk stratification criteria for patients with variceal bleeding","volume":"16","author":"Conejo","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib72","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cgh.2017.08.035","article-title":"Management of acute variceal hemorrhage as a model of individualized care for patients with cirrhosis","volume":"16","author":"Garcia-Tsao","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib73","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.1840160607","article-title":"Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients","volume":"16","author":"Sarin","year":"1992","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.suc.2021.09.005_bib74","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1055\/s-2007-966591","article-title":"A\u00a0prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding","volume":"39","author":"Lo","year":"2007","journal-title":"Endoscopy"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib75","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-0032-1312573","article-title":"Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes","volume":"29","author":"Saad","year":"2012","journal-title":"Semin Intervent Radiol"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib76","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s10620-014-3485-8","article-title":"Balloon-occluded retrograde transvenous obliteration (BRTO) for treatment of gastric varices: review and meta-analysis","volume":"60","author":"Park","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.suc.2021.09.005_bib77","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bpg.2013.08.004","article-title":"Variceal and other portal hypertension related bleeding","volume":"27","author":"Turon","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib78","first-page":"35","article-title":"Pulmonary vascular complications in portal hypertension and liver disease: a concise review","volume":"78","author":"Porres-Aguilar","year":"2013","journal-title":"Rev Gastroenterol Mex"},{"issue":"7","key":"10.1016\/j.suc.2021.09.005_bib79","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.suc.2021.09.005_bib80","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.04.00010904","article-title":"Pulmonary-hepatic vascular disorders (PHD)","volume":"5","author":"Rodriguez-Roisin","year":"2004","journal-title":"Eur Respir J"},{"issue":"17","key":"10.1016\/j.suc.2021.09.005_bib81","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.suc.2021.09.005_bib82","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups","volume":"11","author":"Swanson","year":"2008","journal-title":"Am J Transpl"},{"key":"10.1016\/j.suc.2021.09.005_bib83","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1378\/chest.11-0160","article-title":"Portopulmonary hypertension: a report from the US-based REVEAL Registry","volume":"4","author":"Krowka","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.suc.2021.09.005_bib84","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1053\/jlts.2002.35554","article-title":"Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates","volume":"11","author":"Cotton","year":"2002","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.suc.2021.09.005_bib85","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2021.09.005_bib86","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension","volume":"1","author":"Provencher","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib87","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2020.02.021","article-title":"Portopulmonary hypertension in the current era of pulmonary hypertension management","volume":"73","author":"Savale","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.suc.2021.09.005_bib88","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1056\/NEJMra0707185","article-title":"Hepatopulmonary syndrome--a liver-induced lung vascular disorder","volume":"22","author":"Rodriguez-Roisin","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.suc.2021.09.005_bib89","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.20658","article-title":"Natural history of hepatopulmonary syndrome: Impact of liver transplantation","volume":"41","author":"Swanson","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2021.09.005_bib90","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cgh.2006.12.003","article-title":"Utility of pulse oximetry screening for hepatopulmonary syndrome","volume":"6","author":"Arguedas","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib91","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/hep.26070","article-title":"Hepatopulmonary syndrome: favorable outcomes in the MELD exception era","volume":"57","author":"Iyer","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.suc.2021.09.005_bib92","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.suc.2021.09.005_bib93","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/lt.25328","article-title":"A\u00a0validated score predicts acute kidney injury and survival in patients with alcoholic hepatitis","volume":"24","author":"Sujan","year":"2018","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.suc.2021.09.005_bib94","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.suc.2021.09.005_bib95","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib96","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/kisup.2012.7","article-title":"Summary of recommendation statements","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib97","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib98","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","article-title":"Acute kidney injury in decompensated cirrhosis","volume":"62","author":"Tsien","year":"2013","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib99","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","article-title":"New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection","volume":"145","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2011.09.011","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis","volume":"10","author":"Altamirano","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.suc.2021.09.005_bib101","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/hep.29303","article-title":"Significance of oliguria in critically ill patients with chronic liver disease","volume":"66","author":"Amathieu","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib102","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.suc.2021.09.005_bib103","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2016.09.156","article-title":"Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol 03"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib104","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.29772","article-title":"Fractional excretion of urea: a simple tool for the differential diagnosis of acute kidney injury in cirrhosis","volume":"68","author":"Patidar","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.suc.2021.09.005_bib105","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2020.03.016","article-title":"Clinical application of kidney biomarkers in cirrhosis","volume":"76","author":"Allegretti","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib106","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib107","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2021.09.005_bib108","doi-asserted-by":"crossref","first-page":"m2687","DOI":"10.1136\/bmj.m2687","article-title":"Hepatorenal syndrome: pathophysiology, diagnosis, and management","volume":"370","author":"Simonetto","year":"2020","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.suc.2021.09.005_bib109","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/j.ajkd.2011.07.017","article-title":"Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials","volume":"58","author":"Velez","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib110","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2468-1253(16)30157-1","article-title":"Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis","volume":"2","author":"Facciorusso","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.suc.2021.09.005_bib111","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of Type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib112","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cgh.2016.07.016","article-title":"Terlipressin improves renal function and reverses hepatorenal syndrome in patients with systemic inflammatory response syndrome","volume":"15","author":"Wong","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib113","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/apt.15836","article-title":"Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome","volume":"52","author":"Moore","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.suc.2021.09.005_bib114","article-title":"Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome","volume":"6","author":"Allegretti","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.suc.2021.09.005_bib115","article-title":"Terlipressin versus other vasoactive drugs for hepatorenal syndrome","volume":"9","author":"Israelsen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.suc.2021.09.005_bib116","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.30208","article-title":"Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure","volume":"71","author":"Arora","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib117","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2215\/CJN.03610417","article-title":"Prognosis of patients with cirrhosis and AKI who initiate RRT","volume":"13","author":"Allegretti","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.suc.2021.09.005_bib118","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.xkme.2020.09.015","article-title":"Acute kidney injury treatment in decompensated cirrhosis: a focus on kidney replacement therapy","volume":"3","author":"Allegretti","year":"2021","journal-title":"Kidney Med"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610921001213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610921001213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:13:32Z","timestamp":1758539612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610921001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0039610921001213"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2021.09.005","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Decompensated Cirrhosis and Associated Syndromes","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2021.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}